Rafael Silva

Jan 7, 2025 | etftrends.com | Rafael Silva

The ROBO Global Healthcare Technology and Innovation Index (HTEC) returned -2.9% during the quarter, closing the year with an annual gain of 3.5%, outperforming the MSCI World Health Care Sector, which posted losses of -10.68% and -5.14% for the same period. HTEC saw four out of the nine subsectors delivering positive results.

Oct 21, 2024 | etftrends.com | Rafael Silva

In this ROBO Global Artificial Intelligence Index spotlight, we focus on Veracyte (VCYT). The index underlies the $137 million ROBO Global Artificial Intelligence ETF (THNQ). Here, we explore what makes Veracyte unique within the Healthcare Subsector and dive into its recent performance. Founded in 2006, Veracyte is a global diagnostics company. It is a leader in non-invasive testing for various cancers and interstitial lung diseases.

Oct 16, 2024 | etftrends.com | Rafael Silva

In this ROBO Global Healthcare Technology and Innovation Index spotlight, we focus on Axogen (AXGN). The index underlies the $56.2 million ROBO Global Healthcare Technology and Innovation ETF (HTEC). Here, we explore what makes Axogen unique within the Regenerative Medicine Subsector and dive into its recent performance. Axogen pioneers off-the-shelf tissue products for nerve repair. No other company focuses exclusively on this segment.

Oct 11, 2024 | etftrends.com | Rafael Silva

In this ROBO Global Robotics and Automation Index spotlight, we focus on Omnicell Inc (OMCL). The index underlies the $1.13 billion ROBO Global Robotics and Automation ETF (ROBO). Here, we explore what makes Omnicell unique within the Healthcare Subsector and dive into its recent performance. Omnicell is a leading provider of medication management solutions. It is revolutionizing pharmacy care delivery through a combination of robotics, smart devices, software, and services.

Oct 10, 2024 | mdpi.com | Rafael Silva |Esteban Gonzalez |Andres Inostroza |Gustavo Morales Pavez

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.